[Glyvenol in the treatment of post-thrombophlebitic syndrome of the extremities].
D000328:Adult; D000368:Aged; D000893:Anti-Inflammatory Agents / Q000494:pharmacology / Q000627:therapeutic use*; D001593:Benzyl Compounds / Q000494:pharmacology / Q000627:therapeutic use; D004341:Drug Evaluation; D005121:Extremities / Q000098:blood supply*; D005260:Female; D005947:Glucose / Q000494:pharmacology / Q000627:therapeutic use; D006027:Glycosides / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008833:Microcirculation / Q000187:drug effects; D008875:Middle Aged; D013577:Syndrome; D013924:Thrombophlebitis / Q000188:drug therapy*
D000893:Anti-Inflammatory Agents; D001593:Benzyl Compounds; D006027:Glycosides; D005947:Glucose
Stosowanie glyvenolu w zespole pozakrzepowym kończyn